These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 11563821)
1. Human umbilical cord blood cells ameliorate Alzheimer's disease in transgenic mice. Ende N; Chen R; Ende-Harris D J Med; 2001; 32(3-4):241-7. PubMed ID: 11563821 [TBL] [Abstract][Full Text] [Related]
2. Parkinson's disease mice and human umbilical cord blood. Ende N; Chen R J Med; 2002; 33(1-4):173-80. PubMed ID: 12939116 [TBL] [Abstract][Full Text] [Related]
3. The potential for the use of mononuclear cells from human umbilical cord blood in the treatment of amyotrophic lateral sclerosis in SOD1 mice. Chen R; Ende N J Med; 2000; 31(1-2):21-30. PubMed ID: 10998753 [TBL] [Abstract][Full Text] [Related]
4. Human umbilical cord blood cells ameliorate Huntington's disease in transgenic mice. Ende N; Chen R J Med; 2001; 32(3-4):231-40. PubMed ID: 11563820 [TBL] [Abstract][Full Text] [Related]
5. NOD/LtJ type I diabetes in mice and the effect of stem cells (Berashis) derived from human umbilical cord blood. Ende N; Chen R; Mack R J Med; 2002; 33(1-4):181-7. PubMed ID: 12939117 [TBL] [Abstract][Full Text] [Related]
6. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease. Pihlaja R; Koistinaho J; Malm T; Sikkilä H; Vainio S; Koistinaho M Glia; 2008 Jan; 56(2):154-63. PubMed ID: 18004725 [TBL] [Abstract][Full Text] [Related]
7. Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease. Van Broeck B; Vanhoutte G; Pirici D; Van Dam D; Wils H; Cuijt I; Vennekens K; Zabielski M; Michalik A; Theuns J; De Deyn PP; Van der Linden A; Van Broeckhoven C; Kumar-Singh S Neurobiol Aging; 2008 Feb; 29(2):241-52. PubMed ID: 17112635 [TBL] [Abstract][Full Text] [Related]
8. Expression of transgenic APP mRNA is the key determinant for beta-amyloid deposition in PS2APP transgenic mice. Ozmen L; Albientz A; Czech C; Jacobsen H Neurodegener Dis; 2009; 6(1-2):29-36. PubMed ID: 19066434 [TBL] [Abstract][Full Text] [Related]
9. mTOR/p70S6k signalling alteration by Abeta exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer's disease. Lafay-Chebassier C; Paccalin M; Page G; Barc-Pain S; Perault-Pochat MC; Gil R; Pradier L; Hugon J J Neurochem; 2005 Jul; 94(1):215-25. PubMed ID: 15953364 [TBL] [Abstract][Full Text] [Related]
10. Central cholinergic functions in human amyloid precursor protein knock-in/presenilin-1 transgenic mice. Hartmann J; Erb C; Ebert U; Baumann KH; Popp A; König G; Klein J Neuroscience; 2004; 125(4):1009-17. PubMed ID: 15120860 [TBL] [Abstract][Full Text] [Related]
11. Astrocytic expression of the Alzheimer's disease beta-secretase (BACE1) is stimulus-dependent. Hartlage-Rübsamen M; Zeitschel U; Apelt J; Gärtner U; Franke H; Stahl T; Günther A; Schliebs R; Penkowa M; Bigl V; Rossner S Glia; 2003 Jan; 41(2):169-79. PubMed ID: 12509807 [TBL] [Abstract][Full Text] [Related]
12. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice. van Groen T; Kiliaan AJ; Kadish I Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076 [TBL] [Abstract][Full Text] [Related]
13. Noggin and BMP4 co-modulate adult hippocampal neurogenesis in the APP(swe)/PS1(DeltaE9) transgenic mouse model of Alzheimer's disease. Tang J; Song M; Wang Y; Fan X; Xu H; Bai Y Biochem Biophys Res Commun; 2009 Jul; 385(3):341-5. PubMed ID: 19463786 [TBL] [Abstract][Full Text] [Related]
14. The presence of the APP(swe) mutation in mice does not increase the vulnerability of cholinergic basal forebrain neurons to neuroinflammation. Wenk GL; McGann-Gramling K; Hauss-Wegrzyniak B Neuroscience; 2004; 125(3):769-76. PubMed ID: 15099690 [TBL] [Abstract][Full Text] [Related]
15. An in vitro and in vivo study of early deficits in associative learning in transgenic mice that over-express a mutant form of human APP associated with Alzheimer's disease. Domínguez-del-Toro E; Rodríguez-Moreno A; Porras-García E; Sánchez-Campusano R; Blanchard V; Laville M; Böhme GA; Benavides J; Delgado-García JM Eur J Neurosci; 2004 Oct; 20(7):1945-52. PubMed ID: 15380017 [TBL] [Abstract][Full Text] [Related]
16. Targeted introduction of V642I mutation in amyloid precursor protein gene causes functional abnormality resembling early stage of Alzheimer's disease in aged mice. Kawasumi M; Chiba T; Yamada M; Miyamae-Kaneko M; Matsuoka M; Nakahara J; Tomita T; Iwatsubo T; Kato S; Aiso S; Nishimoto I; Kouyama K Eur J Neurosci; 2004 May; 19(10):2826-38. PubMed ID: 15147316 [TBL] [Abstract][Full Text] [Related]
17. Genomic analysis of response to traumatic brain injury in a mouse model of Alzheimer's disease (APPsw). Crawford FC; Wood M; Ferguson S; Mathura VS; Faza B; Wilson S; Fan T; O'Steen B; Ait-Ghezala G; Hayes R; Mullan MJ Brain Res; 2007 Dec; 1185():45-58. PubMed ID: 17961517 [TBL] [Abstract][Full Text] [Related]
18. A decade of modeling Alzheimer's disease in transgenic mice. McGowan E; Eriksen J; Hutton M Trends Genet; 2006 May; 22(5):281-9. PubMed ID: 16567017 [TBL] [Abstract][Full Text] [Related]